Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen
Schooler, N.R.; Levine, J.; Severe, J.B.
Psychopharmacology Bulletin 15(2): 44-47
1979
ISSN/ISBN: 0048-5764 PMID: 373006 Document Number: 148149
Document emailed within 1 workday
Related Documents
Niturad, A.; Ciurezu, T.; Cucu, I. 1974: Maintenance treatment of schizophrenia with long-acting fluphenazine Activitas Nervosa Superior 16(3): 167Raemaekers, J.; De Witte, T.; Schattenberg, A.; Van der Lely, N. 1989: Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines Bone Marrow Transplantation 4(2): 167-171
Marder, S.R.; Van Putten, T.; Aravagiri, M.; Hubbard, J.W.; Hawes, E.M.; McKay, G.; Midha, K.K. 1989: Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine Psychopharmacology Bulletin 25(3): 479-482
Levine, J.; Schooler, N.R.; Severe, J.; Escobar, J.; Gelenberg, A.; Mandel, M.; Sovner, R.; Steinbook, R. 1980: Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study Advances in Biochemical Psychopharmacology 24: 483-493
Kenway, A.K.; Masheter, H.C. 1971: Pimozide compared with fluphenazine in schizophrenia British Journal of Clinical Practice 25(2): 69-72
Grosser, H.H. 1970: Experience of psychiatric management of schizophrenia with fluphenazine decanoate Diseases of the Nervous System 31(Suppl): 32-36
Takano, A.; Miyamoto, Y.; Kawakami, N.; Matsumoto, T. 2016: The potential of e-Health for treatment and prevention for drug dependence process of development and revision of web-based relapse prevention program "e-SMARPP" Nihon Arukoru Yakubutsu Igakkai Zasshi 51(6): 382-392
Pempkowiak, L.; Januszkiewicz-Grabiasowa, A.; Góra, S. 1979: Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia Psychiatria Polska 13(1): 1-8
Brosteanu, E.R.; Floru, L. 1977: The behaviour of visually evoked potentials (VEP) in schizophrenia under gradually rising doses of fluphenazine dihydrochloride Arzneimittel-Forschung 27(6): 1231-1233
Levenson, A.J.; Burnett, G.B.; Nottingham, J.D.; Sermas, C.E.; Thornby, J.I. 1976: Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol Current Therapeutic Research 20(5): 695-700
Kondo, A.; Kuritsubo, C.; Shirakawa, Y.; Matsumoto, T. 2016: Effectiveness evaluation of Serigaya Methamphetamine Relapse Prevention Program in drug addiction rehabilitation center Nihon Arukoru Yakubutsu Igakkai Zasshi 51(6): 414-424
Thompson, M.H.; Venables, C.W. 1976: The prevention of relapse in duodenal ulceration by long-term nocturnal metiamide treatment Gut 17(5): 389
Verdoux, H.él.èn. 2013: Factors associated with risk of relapse and outcome of persons with schizophrenia La Revue du Praticien 63(3): 343-348
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Johnson, D.A. 1984: Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia Journal of Clinical Psychiatry 45(5 Part 2): 13-21
Bär, B.M.; Schattenberg, A.; De Man, A.J.; Hoogenhout, M.J.; Boezeman, J.; de Witte, T. 1992: Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow Bone Marrow Transplantation 10(1): 45-52
Paster, R.Z.; McAdoo, M.A.; Keyserling, C.H.; Nemeth, M.A.; Tack, K.J.; Griffin, T.J. 2000: A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis International Journal of Clinical Practice 54(5): 293-299
Eufe, R.; Wegener, G. 1979: Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia Der Nervenarzt 50(8): 534-539
L.P.ole, C.; Weijmer, M.; Van Ittersum, F.; Valentijn, R.; Ter Wee, P. 2002: Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs or a standard PD regimen in newly CAPD patients Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 200A
Dmitriev, A.A.; Bektimirov, R.A.; Nikolaenko, E.M. 1982: Evaluation of variants in the approach to vessels in the hemosorption operation in relation to the treatment regimen and procedure Anesteziologiia i Reanimatologiia 1: 35-37